Inventor · disambiguated record
Lisa Leary
Also filed as: LEARY LISA
3 granted patents·4 pending applications·8 citations·filing 2010–2017
59Inventor score
Technology areasA61P
Top patents by PatentIndex Score
7 records- 0181US9119843B2Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCHEN HAO·Filed 2010·Granted Sep 1, 2015·8 cites·8 claims
- 0256US9149466B2Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2014·Granted Oct 6, 2015·0 cites·15 claims
- 0351US8691853B2Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCHEN HAO·Filed 2011·Granted Apr 8, 2014·0 cites·15 claims
- 0451US2017239224A1Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2017·Application pending·0 cites
- 0546US2017056379A1Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCALIPER LIFE SCIENCES INC·Filed 2016·Application pending·0 cites
- 0646US2016095839A1Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressionsCALIPER LIFE SCIENCES INC·Filed 2015·Application pending·0 cites
- 0743US2015366846A1Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditionsCALIPER LIFE SCIENCES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lisa Leary files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →